Ace Molecules Private Limited - Company Profile

It is a chemicals private limited company based in Vijayawada, Andhra Pradesh, India, established in 2012.
2012 Vijayawada, Andhra Pradesh, India Struck Off
Last Updated:
Access Report
About Ace Molecules Private Limited

Ace Molecules Private Limited, a struck off private limited company, was established on 18 September 2012 in Vijayawada, Andhra Pradesh, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24100AP2012PTC083191. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Fathima Mohammad (Director), Sadik Basha Mohammad (Director). Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 31 March 2013. It is based at D No 42-68-31A Block No 17 Ajith Singhnagar Mutyalampadu Area, Vijayawada, Andhra Pradesh, 520015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100AP2012PTC083191

  • Registration Number

    083191

  • Incorporation Date

    18 September 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 4 Months
  • Last Filing with ROC 31 Mar 2013
Company report

Ace Molecules Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ace Molecules Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Ace Molecules Private Limited?
Current Directors
Name Designation Appointment Date Status
Fathima Mohammad Director 18 Sep 2012 Current
Sadik Basha Mohammad Director 18 Sep 2012 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ace Molecules.

Enhance accessibility to Ace Molecules's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Ace Molecules revenue growth over time
Ace Molecules profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ace Molecules?

Unlock access to Ace Molecules's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ace Molecules?

Unlock and access historical data on people associated with Ace Molecules, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ace Molecules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ace Molecules's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ace Molecules
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Ace Molecules Private Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Ace Molecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Vijayawada. was completed.

  • Director Appointment

    The activity Fathima Mohammad was appointed as a Director was appointed as a Director on 18 Sep 2012 & has been associated with this company since 13 years 4 months . was completed.

  • Director Appointment

    Progress on Sadik Basha Mohammad was appointed as a Director was appointed as a Director on 18 Sep 2012 & has been associated with this company since 13 years 4 months . was documented.

  • Company Incorporation

    The activity Ace Molecules Private Limited was registered on 18 Sep 2012 with Roc Vijayawada & aged 13 years 4 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ace Molecules Private Limited?

The CIN of Ace Molecules Private Limited is U24100AP2012PTC083191.

Where is Ace Molecules Private Limited headquartered?

Ace Molecules Private Limited is headquartered at D No 42-68-31A Block No 17 Ajith Singhnagar Mutyalampadu Area, Vijayawada, Andhra Pradesh, 520015.

When was Ace Molecules Private Limited incorporated?

Ace Molecules Private Limited was incorporated on 18 September 2012.

Who are the current directors of Ace Molecules Private Limited?

The current directors of Ace Molecules Private Limited are

What is the primary industry of Ace Molecules Private Limited?

The primary industry of Ace Molecules Private Limited is Chemicals.

Is Ace Molecules Private Limited a listed company?

Ace Molecules Private Limited is unlisted.

What is the capital structure of Ace Molecules Private Limited?

The authorized capital of Ace Molecules Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available